ODC1 and cardiac hypertrophy: For example, the Odc1 inhibitor DFMO successfully blocked cardiac hypertrophy normally associated with clenbuterol [35,36], and overexpression of Odc1 in a transgenic model resulted in a significant increase in BA stimulated cardiac hypertrophy relative to non-transgenic mice [37].